November, 2012

Results of Annual General Meeting

Change of Director’s Interest Notice: Washer

Change of Director’s Interest Notice: Dantzker

Change of Director’s Interest Notice: Korten

Change of Director’s Interest Notice: Haghighat

Change of Director’s Interest Notice: MacDonald

October, 2012

iSonea Q1 Report 2013

ISN ASX Confirm Rights Issue Shortfall

Notice of Annual General Meeting and Explanatory Memorandum

Dispatch of Renounceable Pro-Rate Rights Issue Prospectus

iSonea Files FDA Submission for Over-the-Counter SonoSentry™

September, 2012

2012 Annual Report

Letter to Eligible Shareholders on Rights Issue

Letter to Ineligible Shareholders on Rights Issue

iSonea Announces Fully Underwritten Renounceable Rights Issue to Raise $4M

Appendix 3B: application for quotation of additional securities and agreement

Prospectus: Offer to Eligible Shareholders

Letter to Option Holders

iSonea App Now Free





Please note that by accessing and browsing this website (the "Site") you accept, without limitation or qualification, the Terms and Conditions and acknowledge that any other agreements between you and iSonea (Israel) Ltd. ("KSI") concerning the Site are superseded to the extent they conflict with these Terms and Conditions.

Terms and Conditions

KSI offers products and services to diagnose and treat disease. Its medical devices are regulated by government agencies in each of the countries in which it does business, such as the Food and Drug Administration in the United States or the Therapeutic Goods Administration in Australia. These regulations often restrict the prescribing information that can be disclosed to the public so that you need to consult with your health care professional.

The Site has been developed as a service of KSI. The information in the Site may become out of date over time. Nothing on the Site should be construed as the giving of medical advice or the making of a recommendation and it should not be relied upon as the basis for any decision or action. It is important that you rely only on the advice of a health care professional regarding your specific situation. KSI accepts no liability for the accuracy or completeness or use of, nor any liability to update, the information contained on the Site. These materials are provided "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. Some jurisdictions do not allow the exclusion of implied warranties, so the above exclusion may not apply to you.

Nothing on this Site constitutes an invitation or offer to invest or deal in the securities of KSI parent company iSonea LTD (Australia). The Site has been designed to provide general information about KSI and its products. In particular, actual results and developments may be materially different from any forecast, opinion or expectation expressed on the Site and the past performance of the price of securities must not be relied on as a guide to their future performance. Investors must not rely on the information included in or referred from the Site for investment decisions.

The Site may link you to other websites on the Internet, including the websites for KSI affiliates in other countries. KSI cannot take responsibility for information found on third party websites outside its control or on any other site other than this Site. While KSI attempts to provide links only to third-party websites that comply with all applicable laws and regulations and KSI's standards, please understand that the content on these third-party websites is subject to change without notice to KSI. We therefore cannot be responsible for, and accept no liability for, any information or opinion contained in any third-party web site or in any other site other than this Site.

Copyright and Intellectual Property

Text, images, videos, applications and other materials displayed on the Site are either the property of, or used with permission by, KSI. The use of these images and/or materials, is prohibited unless specifically permitted by these Terms and Conditions or as provided elsewhere on the Site. None of the materials may be copied, reproduced, distributed, downloaded, displayed, or transmitted in any form or by any means without the prior written permission of KSI or the copyright owner. Any unauthorized use of such material may violate inter alia copyright laws, trademark laws, the laws of privacy and publicity, and communications regulations and statutes. You are also advised that KSI will aggressively enforce its intellectual property rights to the fullest extent of the law, including the seeking of criminal prosecution.

Communicating with KSI

We are happy to have you contact us by telephone, surface mail, email or facsimile transmission. However, please do not convey to us any personal, medical or confidential information and please also note that any information you convey to us via the internet or email, may not be secure. Should any viewer of a KSI published document or this Site respond with information including feedback data such as questions, comments, suggestions, or the like regarding the content of any such KSI material, such information shall be deemed to be non-confidential and we shall have no obligation of any kind with respect to such information and shall be free to reproduce, use, disclose, and distribute the information to others without limitation. We shall be free to use any ideas, concepts, know-how or techniques contained in such information for any purpose whatsoever including but not limited to developing, manufacturing and marketing products incorporating such information.

© 2012 iSonea (formerly Karmelsonix) Ltd| Disclaimer, Terms and Conditions, Copyright and Intellectual Property.

BlackFin Processor
BlackFin® Processor
KarmelSonix ISO Certification
ISO Certification 2003
US Food & Drug Administration

US Food & Drug Administration
Australian Government

Australian Government
Therapeutic Goods Administration

CE Certification

CE Certification